US/Italy: Cyberonics, Italy’s Sorin merge to create medical technology leader
Sorin a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics a medical device company with core expertise in neuromodulation, announced on Thursday their merger plan to create a new global leader in medical technologies with a combined equity value of approximately $2.7 billion.
Featured News
Film Producers Raise Antitrust Concerns Over Paramount-Warner Deal
Jul 30, 2026 by
CPI
EU Signals ChatGPT, Roblox Could Face Expanded Digital Services Rules
Jul 30, 2026 by
CPI
OpenAI, Trump Administration Discuss Voluntary AI Safety Testing
Jul 30, 2026 by
CPI
SAP Says German Antitrust Authority Ends Preliminary Review Without Formal Case
Jul 30, 2026 by
CPI
Keystone Launches Washington Antitrust Practice With 2 Former DOJ Officials
Jul 30, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes